Novo Nordisk partners with ORA for digital obesity care program in the country.

 Novo Nordisk and ORA officially seal their partnership to revolutionize obesity care in the Philippines through telehealth.

Photo shows (seated from left): Thalia Bondoc, director for marketing, ORA, Tom Reynolds, vice president for marketing, ORA, Wei Sun, general manager of Novo Nordisk Philippines, and Geraldine Perez, market access & business development director of Novo Nordisk Philippines. Joining them are key colleagues from both Novo Nordisk Philippines and ORA who made this partnership possible.

 The collaboration brings together Novo Nordisk’s clinical expertise and ORA’s fully digital care platform to offer end-to-end obesity care—from virtual consultations to personalized plans and medication delivery. The initiative aims to break down barriers of stigma, cost, and limited access to doctor’s care by empowering Filipinos to take charge of their health from the comfort of their homes. 

This forms part of Novo Nordisk’s Truth About Weight (TAW) campaign in the country, which aims to raise awareness, dispel stigma, and encourage informed, science-based approaches to addressing obesity.